The National Women's Cancer Committee (CNCM) has been reactivated with the aim of promoting prevention and comprehensive care policies to reduce the incidence and mortality of cancer in women at the national level. During the reinstatement of the CNCM, the Undersecretary for Prevention and Promotion of Health, Ramiro López Elizalde, highlighted the current administration's commitment to the fight against women's cancer, considering that this disease is one of the leading causes of death among Mexican women.
At the relaunch of the CNCM activities, the Secretary of Health, David Kershenobich, emphasized the government of Claudia Sheinbaum's commitment to prioritizing cancer care in Mexico. Emphasis was placed on strengthening the vaccination strategy against Human Papillomavirus (HPV) and promoting earlier diagnoses to improve patient prognoses. In this sense, more than 9,000 workshops have been conducted across the 32 federal entities to promote self-care in sexual and reproductive health.
The event was attended by various authorities, both federal and state, as well as representatives from civil society and international organizations. The Committee is responsible for designing strategies and coordinating actions to improve the prevention, detection, and care of cancer, monitoring incidence data, and promoting awareness campaigns about risk factors and early detection.
There was an emphasis on intensifying information campaigns about breast cancer, recommending mammograms and ultrasounds starting at certain ages, with the goal of increasing timely diagnoses. The importance of early detection was highlighted, as breast cancer has a good prognosis if detected early, and it was assured that the Health Sector has the necessary resources to provide the best treatment to patients.
Additionally, it was reported that in the current National Vaccination Campaign, more than 900,000 doses against HPV, associated with cervical cancer, have been administered, representing a significant advancement in sectorial coverage. For the upcoming vaccination campaign, there is sufficient supply to reach 100% of the target population.
